| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 01/11/2006 | EP1469887A4 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 01/11/2006 | CN1720049A Therapeutic applications of 2-substituted 4-heteroarylpyrimidines |
| 01/11/2006 | CN1235908C 16,17-carbocyclic condensed steroid compounds having seletive estrogenic activity |
| 01/11/2006 | CN1235641C Medicinal aerosol formulation, its preparing process, use and inhaler containing same |
| 01/11/2006 | CN1235570C Microball preparation for intestine orient releasing medicine and its preparing method |
| 01/10/2006 | US6984623 Tendon-inducing compositions |
| 01/10/2006 | US6984405 Compositions for inducing secretion of insulin-like growth factor-1 |
| 01/10/2006 | CA2406745C A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 01/10/2006 | CA2370411C Diazabicyclo compounds for the treatment of schizophrenia and other disorders |
| 01/10/2006 | CA2299760C Cyano containing oxamic acids and derivatives as thyroid receptor ligands |
| 01/05/2006 | US20060004077 Inhibiting class II MHC-mediated activation of T cells; peptidomimetics of given sequence which include a Gpg (guanylpiperidyl glycine) unit; rheumatoid arthritis and/or multiple sclerosis; e.g. Ac-Cha-Gpg-Tic-Nle-NHCH2CH2Ph (Cha=cyclohexylalanine, Tic=3-carboxyisoquinoline, Nle=norleucine) |
| 01/05/2006 | US20060004020 Pyrrolidine derivatives as oxytocin antagonists |
| 01/05/2006 | US20060003975 Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor |
| 01/05/2006 | US20060003410 Oxidoreductase for use in identifying modulators for prevention and treatment of diabetes, obesity, dyslipidemia, coronary heart, inflammatory and cancer disorders |
| 01/05/2006 | US20060002861 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist |
| 01/05/2006 | DE102004028284A1 Matrixkontrolliertes transdermales therapeutisches System auf Basis eines Schmelzklebstoffs zur Anwendung von Norelgestromin Controlled matrix transdermal therapeutic system based on a hot melt adhesive for use of norelgestromin |
| 01/05/2006 | CA2571309A1 Chemical compounds |
| 01/04/2006 | EP1612266A2 Prostaglandin reductase |
| 01/04/2006 | EP1612222A2 Olfactory and pheromones G-protein coupled receptors |
| 01/04/2006 | EP1611896A1 Use of n-acetyl-d-aminoglycosamine in treatment of local lesions or systematic symptoms related to autoimmune reactions |
| 01/04/2006 | EP1611892A2 Pharmaceutical compositions comprising drospirenone |
| 01/04/2006 | EP1611887A2 Modulation of peroxisome proliferator-activated receptors |
| 01/04/2006 | EP1611111A2 Process for resolving 2,4-diamino-3,6-dihydro-1,3,5-triazines, useful for the treatment of disorders associated with insulin resistance syndrome |
| 01/04/2006 | EP1242403B1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 01/04/2006 | EP1102755B1 Substituted isoxazole derivatives as estrogen receptor modulators |
| 01/04/2006 | CN1717243A Papaya puree and the use of the same |
| 01/04/2006 | CN1717239A Transdermal therapeutic system containing testosterone and method for the production thereof |
| 01/04/2006 | CN1714869A Anhydrous topical skin preparations |
| 01/04/2006 | CN1234721C Androgenic 7-substituted 11-halogen steroids |
| 01/04/2006 | CN1234417C Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same |
| 01/04/2006 | CN1234350C Estrogen plaster used on pessary or intrauterine device |
| 01/03/2006 | US6982261 A progesterone receptor antagonist for providing progestational therapy, treating cancer of breast, uterine, ovarian, endometrial, or prostate, providing contraceptives, hormone replacement therapy |
| 01/03/2006 | US6982258 Low-calcemic oxime analogs of 1α,25-dihydroxy vitamin D3 |
| 01/03/2006 | CA2329005C Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 12/29/2005 | WO2003033671A3 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 12/29/2005 | US20050289658 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 12/29/2005 | US20050288487 Human mast cell-expressed membrane proteins |
| 12/29/2005 | US20050288356 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 12/29/2005 | US20050288353 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 12/29/2005 | US20050288350 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 12/29/2005 | US20050288325 Therapy for andropause using estrogen agonists/antagonists and testosterone |
| 12/29/2005 | US20050288321 Alzheimer's disease ; 3-(2,3-dihydro-5,6-difluorobenzofur-7-yl)-4-[1-(piperidin-4-yl)-1H-indol-3-yl]pyrrole-2,5-dione; stimulating bone deposition |
| 12/29/2005 | US20050288303 Cyclic protein tyrosine kinase inhibitors |
| 12/29/2005 | US20050288230 Non-steroidal anti-androgen therapy |
| 12/29/2005 | US20050287617 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 12/29/2005 | US20050287195 Transdermal drug delivery systems |
| 12/29/2005 | US20050287168 Recombinant spores |
| 12/28/2005 | EP1609803A1 Modified antibody against cd22 and utilization thereof |
| 12/28/2005 | EP1609478A1 Exendin agonist peptide formulations |
| 12/28/2005 | EP1608396A2 Use of soluble cd14 for treatment of diseases |
| 12/28/2005 | EP1608389A1 Active ingredient combinations of plant oils containing omega-3 fatty acids and plant extracts containing isoprenoids and the use thereof |
| 12/28/2005 | EP1608360A1 Synergistic hepatoprotective composition and a method thereof |
| 12/28/2005 | EP1527076B1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods |
| 12/28/2005 | EP1377593B1 2-amino-propanol derivatives |
| 12/28/2005 | EP1173433B1 Cyanopyrroles as progesterone receptor agonists |
| 12/28/2005 | EP1161418B1 1-acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors |
| 12/28/2005 | CN1714078A Indoles useful in the treatment of androgen-receptor related diseases |
| 12/27/2005 | US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology |
| 12/27/2005 | US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 12/27/2005 | US6979447 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 12/22/2005 | WO2005120552A1 METHODS AND FORMULATIONS OF GnRH/LEUKOTOXIN CHIMERAS FOR TESTOSTERONE SUPPRESSION |
| 12/22/2005 | WO2005120537A1 Composition comprising bamboo extract for androgen agonist |
| 12/22/2005 | WO2005120519A1 Glycosylphosphatidylinositol glycan signalling via integrins functioning as glycan specific receptors |
| 12/22/2005 | WO2005120485A1 Regulator of physiological function of ghrelin and use thereof |
| 12/22/2005 | WO2005120484A1 Regulator for physiological functions of ghrelin |
| 12/22/2005 | WO2005108337A3 Compounds with activity at estrogen receptor |
| 12/22/2005 | WO2003057856A3 Dominant negative proteins and methods thereof |
| 12/22/2005 | US20050282889 Intracorporeal medicaments for photodynamic treatment of disease |
| 12/22/2005 | US20050282882 Diamines as modulators of chemokine receptor activity |
| 12/22/2005 | US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/22/2005 | US20050282872 Novel thyroid receptor ligands and method II |
| 12/22/2005 | US20050282867 Hydrochloride salt of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazo-lidine-2,4-dione |
| 12/22/2005 | US20050282843 Therapeutic applications of 2-substituted 4-heteroarylpyrimidines |
| 12/22/2005 | US20050282789 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system |
| 12/22/2005 | US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 12/22/2005 | US20050281891 Testosterone stimulant |
| 12/22/2005 | CA2569891A1 Glycosylphosphatidylinositol glycan signalling via integrins functioning as glycan specific receptors |
| 12/22/2005 | CA2569678A1 Regulator of physiological function of ghrelin and use thereof |
| 12/21/2005 | EP1606307A1 ESTRIENO(3,2-b)/(3,4-c)PYRROLE DERIVATIVES USEFUL AS MODULATORS OF THE ESTROGEN RECEPTORS |
| 12/21/2005 | EP1606018A2 Use of thyroid-stimulating hormone to induce lipolysis |
| 12/21/2005 | EP1605962A1 Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy |
| 12/21/2005 | EP1605949A2 Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
| 12/21/2005 | EP1605924A2 Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt) |
| 12/21/2005 | EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function |
| 12/21/2005 | EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 12/21/2005 | EP1402267B1 Chp for use as marker for sepsis |
| 12/21/2005 | EP1223915B1 Dry powder compositions having improved dispersivity |
| 12/21/2005 | EP1144431B1 16-hydroxyestratrienes as selective estrogens |
| 12/21/2005 | CN1711079A 3,5,3' -triiodothronine sulfate as thyromimetic agent and pharmaceutical formulations thereof |
| 12/21/2005 | CN1232507C Growth hormone secretagogues |
| 12/21/2005 | CN1232244C Stable non-aqueous single phase viscose carrier and formulations utilizing such carrier |
| 12/20/2005 | US6977294 Process for isolation of eupalitin from Boerhavia diffusa |
| 12/20/2005 | US6977254 For prevention and/or suppression of preterm labor, suppression labor at term prior to caesarean deliver, and for the treatment of dysmenorrhea, useful in enhancing fertility rates |
| 12/15/2005 | WO2005118556A1 Propane-1,3-dione derivative or its salt |
| 12/15/2005 | WO2005117934A1 Sustained release composition |
| 12/15/2005 | US20050277660 Novel tetrahydroquinoline derivatives |
| 12/15/2005 | US20050277590 Includes substitutions/modifications which enhance secretion/degradation resistance; drugs; for insulin release and controlling blood glucose concentration |
| 12/15/2005 | US20050277190 Progenitor cells; differentiation; cloning |
| 12/15/2005 | US20050276853 Chronotherapeutic dosage forms and methods of treatment using chronotherapy |
| 12/15/2005 | US20050276843 An aerosol drug delivery device containing PTH, cyclodextrin, and didecanoylphophatidylcholine that provides droplets of 25 to 700 microns in size; improved bioavailability; osteoporosis |